Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-rkxrd Total loading time: 0 Render date: 2024-07-20T07:38:26.819Z Has data issue: false hasContentIssue false

38 - Possible treatment issues

from Part III - Behavior problems

Published online by Cambridge University Press:  26 October 2009

Get access

Summary

Any therapy, be it drug, surgery, or other approaches, can produce adverse effects in a minority as well as benefits in a majority of patients. The goal is to choose the right therapy for the individual in terms of benefit and tolerance.

Antiepileptic drugs

Antiepileptic medications can produce side effects alone or in combinations with other drugs. In monotherapy, the side effects of the drugs can be noted (Herranz et al., 1988). Any antiepileptic drug may produce emotional problems, especially in young, elderly, and or brain-damaged patients. Milder forms of the behaviors are transient, fading after two to three weeks. More severe and persistent problems may be accentuations of previous tendencies brought out by the drug or may be a pre-existing problem that is later blamed on the drug. The rates of these effects are highly variable (Weisbrot & Ettinger, 1998).

Problems can range from inattention, hyperactivity, or depression to a major psychotic reaction, seen in 1% of patients. Psychiatric reactions are not simply idiosyncratic but depend on the drug's anticonvulsant strength and the patient's genetic and biological psychiatric predisposition. The principal three types of complications are toxic (3%), metabolic (3%), and allergic (1%) (Schmitz, 1999; Vaintrub, 1998). Brain-damaged and retarded children are more susceptible to the adverse behaviors of antiepileptic drugs (Schain, 1983).

The risks for reactions relate to the severity of the epilepsy, polytherapy, rapid drug titration, high dosage, forced normalization, drug withdrawal, and folate deficiency.

Type
Chapter
Information
Childhood Epilepsy
Language, Learning and Behavioural Complications
, pp. 590 - 615
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abou-Khalil, B. & Fakhoury, T. (1998). Neuropsychiatric profile of high-dose topiramate. Epilepsia 38 (suppl 8): 207Google Scholar
Alexander, A., Blumer, D., & Davies, K. G. (1999). Psychiatric complications associated with vagus nerve stimulation. Epilepsia 40 (suppl 7): 208Google Scholar
Barabas, G. & Matthews, W. (1988). Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 82: 284–5Google ScholarPubMed
Barlow, C. F. (1978). Risk Factors of infancy and childhood: interrelationships of seizure disorders and mental retardation. In Mental Retardation and Related Disorders, pp. 768–76. Philadelphia: F. A. Davis
Barry, J. (1998). Treatment of affective and attention deficit disorders. Presented at the American Epilepsy Society Conference, 1998
Bensch, J., Blennow, G., Ferngren, H., et al. (1977). A double-blind study of clonazepam in the treatment of therapy resistant epilepsy in children. Dev. Med. Child Neurol. 19: 335–42CrossRefGoogle ScholarPubMed
Beran, R. G. & Gibson, R. J. (1998). Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 39: 280–82CrossRefGoogle ScholarPubMed
Betts, T., Crawford, P. & Trimble, M. R. (1998). Topiramate and psychoses. 3rd European Congress of Epileptology. Epilepsia 39 (suppl 2): 3Google Scholar
Betts, T., Smith, K. & Khan, G. (1997). Severe psychiatric reactions in topiramate. Epilepsia 38 (suppl 3): 64Google Scholar
Brent, D. A. (1986). Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital 1978–1983. J. Am. Acad. Child Psychiatry 25: 242–6CrossRefGoogle Scholar
Brent, D. A., Crumrine, P. K., Varma, R. R., et al. (1987). Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80: 909–17Google ScholarPubMed
Brodie, M. J. (1996). Monotherapy with vigabatrin. Presented at the Second European Congress of Epileptology, The Hague, the Netherlands, 1996
Brodie, M. J., Richens, A. & Yuen, A. (1995). Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 345: 458–76CrossRefGoogle ScholarPubMed
Browne, T. R., Penry, S. K., Porter, R. S., et al. (1974). Responsiveness before, during, and after spike-wave paroxysms. Neurology 24: 660–65CrossRefGoogle ScholarPubMed
Camfield, C. S., Chaplin, S., Doyle, A. B., et al. (1979). Side effects of phenobarbital in toddlers: behavior and cognitive aspects. Pediatrics 95: 351–65Google ScholarPubMed
Cole, K. D. & Zarit, S. H. (1984). Psychological deficits in depressed medical patients. J. Nerv. Ment. Dis. 172: 150–55CrossRefGoogle ScholarPubMed
Corbett, J. A., Trimble, M. R. & Nichol, T. C. (1985). Behavioral and cognitive impairments in children with epilepsy: the long-term effects of anticonvulsant therapy. J. Am. Acad. Child Psychiatry 24: 17–23CrossRefGoogle ScholarPubMed
Curran, H. V., Java, R. & Luder, M. H. (1991). Cognitive and psychomotor effects of oxcarbamazepine. 9th International Epilepsy Congress. Epilepsia 32 (suppl 10): 56Google Scholar
Dalby, M. A. (1975). Behavioral effects of carbamazepine. In Complex Partial Seizures and their Treatment, ed. J. K. Penry & D. D. Daly, Vol. II, pp. 331–43. New York: Raven Press
Davidson, S. & Falconer, M. A. (1975). Outcome of surgery in 40 children with temporal lobe epilepsy. Lancet 1: 1260–63CrossRefGoogle ScholarPubMed
Devinsky, O. (1998). What should the neurologist remember on the psychopharmacology of epilepsy? Presented at the American Epilepsy Society Conference, 1998
Dodrill, C. B., Arnett, J. L., Shu, V., et al. (1998). Effects of tiagabine monotherapy on abilities, adjustment and mood. Epilepsia 39: 33–42CrossRefGoogle Scholar
Doherty, K. T. & Gates, J. R. (1999). Use of topiramate in the cognitively impaired. Epilepsia 40 (suppl 7): 62Google Scholar
Dohmeier, C., Kay, A. & Greathouse, N. (1998). Neuropsychiatric complications of topiramate therapy. Epilepsia 39 (suppl 6): 189Google Scholar
Drake, M. E. & Peruzzi, W. T. (1986). Manic state with carbamazepine therapy of seizures. J. Natl. Med. Assoc. 78: 1105–7Google ScholarPubMed
Dreifuss, F. (1983). Pediatric Epileptology. Boston, MA: John Wright PSG
Dulac, O., Chiron, C., Luna, D., et al. (1991). Vigabatrin in childhood epilepsy. J. Child Neurol. 6: 2830–37CrossRefGoogle Scholar
Edwards, J. G. (1985). Antidepressants and seizures: epidemiology and clinical aspects. In The Psychopharmacology of Epilpesy, ed. M. R. Trimble, pp. 119–39. New York: John Wiley & Sons
Ettinger, A. B. & Steinberg, A. L. (2001). Psychiatric issues in patients with epilepsy and mental retardation. In Psychiatric Issues in Epilepsy, ed. A. B. Ettinger & A. M. Kanner, pp. 181–200. Philadelphia: Lippincott Williams & Wilkins
Ettinger, A. B., Bernal, O. G., Andriola, M. R., et al. (1999a). Two cases of nonvconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 40: 1159–62CrossRefGoogle Scholar
Ettinger, N. E., Vitale, S., Schindler, R. J., et al. (1999b). Changes in mood and quality of life in adult epilepsy patients treated with vagal nerve stimulation. Epilepsia 40 (suppl 7): 62Google Scholar
Ettinger, A. B., Weisbrot, D. M., Saracco, J., et al. (1998). Positive and negative psychotropic effects of lamotrigine in epilepsy patients with mental retardation. Epilepsia 39: 874–7CrossRefGoogle ScholarPubMed
Faight, E. (2001). Zonisamide. Neurology 67: 1774–9Google Scholar
Farrell, K., Jan, J. E., Julian, J. V., et al. (1984). Clobazam in children with intractable seizures. Epilepsia 25: 657Google Scholar
Favale, E., Rubino, V., Mainardi, P., et al. (1995). Anticonvulsant effect of fluoxetine in humans. Neurology 45: 1925–7CrossRefGoogle ScholarPubMed
Ferrari, M., Barbaras, G. & Matthews, W. (1983). Psychologic and behavioral disturbances among epileptic children treated with barbiturate anticonvulsants. Am. J. Psychiatry 140: 112–13Google Scholar
Ferrie, C. D., Robinson, R. O. & Panaziotopoulos, C. P. (1996). Psychotic and severe Behavioural reactions with vigabatrin: a review. Acta Neurol. Scand. 93: 1–8CrossRefGoogle ScholarPubMed
Fitton, A. & Goa, K. L. (1995). Lamotrigine. Drugs 50: 691–713CrossRefGoogle ScholarPubMed
Freeman, T. W., Clothier, J. L., Pazaglia, P., et al. (2002). A double-blind comparison of valproate and lithium in the treatment of acute mania. Am. J. Psychiatry 149: 108–11Google Scholar
Friedman, D. L., Kastner, T. & Plummer, A. T. (1992). Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine. Am. J. Ment. Retard. 9: 541–6Google Scholar
Fromm, G. H., Amores, C. Y. & Thies, W. (1972). Imipramine in epilepsy. Arch. Neurol. 27: 198–204CrossRefGoogle ScholarPubMed
Fromm, G. H., Rosen, J. A. & Amores, C. Y. (1971). Clinical and experimental investigation on the effects of imipramine on epilepsy. Epilepsia 12: 282Google Scholar
Fromm, G. H., Wessel, H. B., Glass, J. D., et al. (1978). Imipramine in absence and myoclonic seizures. Neurology 28: 953–7CrossRefGoogle Scholar
Frommer, D. A., Kulig, K. W., Marx, J. A., et al. (1987). Tricyclic antidepressant overdose: a review. JAMA 257: 521–6CrossRefGoogle ScholarPubMed
Gadow, K. D. (1982). School involvement in the treatment of seizure disorders. Epilepsia 23: 215–24CrossRefGoogle ScholarPubMed
Ghaemi, S. N., Katzow, J. J., Desai, S. P., et al. (1997). Gabapentin treatment of mood disorders: a preliminary study. J. Clin. Psychiatry 59: 426–9CrossRefGoogle Scholar
Gutierrez, A., Dreifuss, F. E., Santilli, N., et al. (1984). Psychiatric symptoms associated with progabide therapy. Epilepsia 25: 657Google Scholar
Hamiwka, L. D., Gerber, P. E., Connolly, M. B., et al. (1999). Topiramate-associated behavioral changes in children. Epilepsia 40 (suppl 7): 116Google Scholar
Harden, C. (2001). Safety profile of levetiracetam: pharmacological treatment of epilepsy. Epilepsia 42: (suppl 4): 36–9CrossRefGoogle Scholar
Hartlage, L. C., Stovall, K. & Kocack, B. (1980). Behavioral correlates of anticonvulsant blood levels. Epilepsia 21: 185Google Scholar
Hauser, W. A. & Hesdorffer, D. C. (2001). Psychoses, depression and epilepsy: epidemiological considerations. In Psychiatric Issues in Epilepsy, ed. A. B. Ettinger & A. M. Kanne, pp. 7–18. Philadelphia: Lippincott Williams & Wilkins
Helmers, S., Wheless, J. W., Frost, M., et al. (1999). Vagus nerve stimulation (VNS) in children: quality of life and safety. Epilepsia 40 (suppl 7): 121Google Scholar
Herranz, J. L., Armijo, J. A. & Arteaga, R., (1988). Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine and valproate during monotherapy in children. Epilepsia 29: 794–804CrossRefGoogle ScholarPubMed
Herranz, J. L., Arteaga, R. & Armijo, J. A. (1982). Side effects of sodium valproate in monotherapy controlled by plasma levels: a study of 188 pediatric patients. Epilepsia 23: 203–14CrossRefGoogle Scholar
Holdsworth, L. & Whitmore, K. (1974). A study of children with epilepsy attending ordinary schools. I: their seizure patterns, progress, and behavior in schools. Dev. Med. Child Neurol. 16: 746–58CrossRefGoogle ScholarPubMed
Holmes, G. L. (1987). Psychosocial Factors in Childhood Epilepsy, In Diagnosis and Management of Epilepsy in Children, pp. 112–24. Philadelphia: W. B. Saunders
Janssen-Cilag. (1996). Topomax. Product monograph
Jeavons, P. M. (1977). Choice of drug therapy in epilepsy. Practitioner 219: 542–56Google ScholarPubMed
Jick, H., Dinan, B. J., Hunter, J. R., et al. (1983). Tricyclic antidepressants and convulsions. J. Clin. Psychopharmacol. 3: 182–5CrossRefGoogle ScholarPubMed
Kanner, A. M. & Balabanov, A. (2002). Depression and epilepsy: how closely related are they?Neurology 58 (suppl 5): 27–39CrossRefGoogle Scholar
Kanner, A. M., Faught, E., French, A. J., et al. (2000). Psychiatric adverse events caused by topiramate and lamotrigine: A post marketing prevalence and risk study. Epilepsia 41 (suppl 7): 169Google Scholar
Kasumakar, V. & Yatham, L. N. (1997). An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 19: 145–8CrossRefGoogle Scholar
Kaufman, K. R., Kugler, S. L., Sachdeo, R. C., et al. (1999). Tiagabine in the management of post-encephalitic epilepsy and impulse control disorders. Epilepsia 40 (suppl 7): 57Google Scholar
Kendrick, A. M., Duncan, J. S. & Trimble, M. R. (1993). Effects of discontinuation of individual antiepileptic drugs on mood. Hum. Psychopharmacol. 8: 263–70CrossRefGoogle Scholar
Ketter, T. A., Nalow, B. A., Flamini, R., et al. (1994). Anticonvulsant withdrawal-emergent psychopathology. Neurology 44: 55–61CrossRefGoogle ScholarPubMed
King, J. A. (1994). Increased incidence of adverse behavioral side effects associated with the addition of felbamate (FBM) to antiepileptic drug (AED) regimens in the mentally retarded (MR) population. Epilepsia 36: (suppl 8): 94Google Scholar
Kinsbourne, M. & Caplan, P. J. (1979). Cognitive power disorders. In Children's Learning and Attention Problems, p. 232 Boston, MA: Little Brown & Co
Knoll, J.Stegman, K. & Suppes, T. (1998). Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J. Affect. Disord. 49: 229–33CrossRefGoogle ScholarPubMed
Kossoff, E. H., Bergey, G. K., Freeman, J. M., et al. (2002). Levetiracetam psychosis in children with epilepsy. Epilepsia 42: 1611–13CrossRefGoogle Scholar
Kulig, B. M. (1980). The evaluation of the behavioral effects of antiepileptic drugs in animals and man. In Epilepsy and Behavior'79, ed. B. M. Kulig, H. Meinardi & G. Stores, pp. 47–61. Lisse: Swets & Zeitlinger
Lambert, M. V. & Robertson, M. M. (1999). Depression in epilepsy: etiology, phenomenology and treatment. Epilepsia 40 (suppl 10): 21–47CrossRefGoogle ScholarPubMed
Landolt, H. (1958). Serial electroencephalographic investigations during psychotic episodes in epileptic patients during schizophrenic attacks. In Lectures on Epilepsy, ed. L. DeHass. London: Elsevier
Leach, J. P. & Brodie, M. J. (1998). Drug profile: tiagabine. Lancet 351: 203–7CrossRefGoogle Scholar
Lee, D. O., Steingard, R. J., Cesena, J. M., et al. (1995). Behavioral side effects of gabapentin in children. Epilepsia 37: 87–90CrossRefGoogle Scholar
Leppik, E. (1995). Tiagabine: the safety landscape. Epilepsia 36 (suppl 6): 10–13CrossRefGoogle ScholarPubMed
Loiseau, P., Psestre, M., Dartigues, J., et al. (1983). Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann. Neurol. 13: 642–8CrossRefGoogle ScholarPubMed
Loiseau, P., Strube, E., Torr, U. J., et al. (1998). Evaluation neuropsychologique et therapeutique du stirpentol dans, l'epilepsie. Rev. Neurol. 144: 165–77Google Scholar
Luef, G. & Bauer, G. (1996). Topiramate in drug-resistant partial and generalized epilepsies. Epilepsia 37 (suppl 4): 69Google Scholar
Manchanda, R., Miller, H., McLachlan, R. S., et al. (1996). Psychiatric disorders in candidates for surgery for epilepsy. J. Neurol. Neurosurg. Psychiatry 61: 82–9CrossRefGoogle ScholarPubMed
Mandlebaum, D. E., Kugler, S. L., Wenger, E. C., et al. (2001). Clinical experience with levetiracetam and zonisamide in children with uncontrolled epilepsy. Epilepsia 42 (suppl 7): 183Google Scholar
Marcotte, D. (1998). Topiramate in the treatment of mood disorders. Proceedings of the 151st Annual Meeting of the American Psychiatric Association. Toronto: American Psychiatric Association
Mayeux, R., Brandt, J., Rosen, J., et al. (1980). Interictal memory and language impairment in temporal lobe epilepsy. Neurology 30: 120–25CrossRefGoogle ScholarPubMed
McDanal, C. E. & Bolman, W. M. (1975). Delayed idiosyncratic psychosis with diphenylhydantoin. JAMA 231: 1063CrossRefGoogle ScholarPubMed
McElroy, S. L., Soutullo, C. A., Keck, P. E., et al. (1997). A pilot trial of adjunctive gabapentin in the treatment of bipolar disease. Ann. Clin. Psychiatry 6: 99–103CrossRefGoogle Scholar
Meador, K. J., Loring, D. W., Ray, P. G., et al. (2001). Differential cognitive and behaivoral effects of carbamazepine and lamotrigine. Neurology 56: 1177–83CrossRefGoogle ScholarPubMed
Morris, G. L. & Mueller, W. M. (1999). Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology 53: 1731–5CrossRefGoogle ScholarPubMed
Nemeroff, C. B., DeVane, C. L. & Pollock, B. G. (1995). Newer antidepressants and the cytochrome P450 system. Am. J. Psychiatry 153: 311–20Google Scholar
Numberger, J. I. Jr, Berrettini, W. H., Simmons-Alling, S., et al. (1986). Intravenous GABA administration is anxiolytic in man. Psychiatry Res. 19: 113–17CrossRefGoogle Scholar
Ozdirim, E., Renda, Y. & Eupur, S. (1978). Effects of phenytoin and phenobarbital on the behavior of epileptic children. In Advances in Epileptology 1977: Psychology, Pharmacotherapy and New Diagnostic Approaches, ed. H. Meinardi & A. Rowan, pp. 120–23. Amsterdam: Swets & Zeitlinger
Perrine, K. & Congett, S. (1994). Neurobehavioral problems in epilepsy. In Neurology Clinics, ed. O. Devinsky, pp. 129–252. Philadelphia: W. B. SaundersCrossRef
Pollack, M. H., Matthews, J. & Scott, E. L. (1998). Gabapentin as a potential treatment for anxiety disorders. Am. J. Psychiatry 155: 992CrossRefGoogle ScholarPubMed
Post, R. M., Ketter, T. A., Denicoff, K., et al. (1996). The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128: 115–29CrossRefGoogle ScholarPubMed
Pratt, J. A., Jenner, P., Johnson, A. L., et al. (1984). Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic actions and mental function. J. Neurol. Neurosurg. Psychiatry 47: 1131–3CrossRefGoogle Scholar
Rausch, R. 1991 Effects of temporal lobe surgery on behavior. In Neurobehavioral Problems in Epilepsy, Advances in Neurology, ed. D. B. Smith & D. B. Treiman, Vol. 55, pp. 279–92. New York: Raven Press
Ravdin, L. S. D., Harden, C. L., Correa, D. D., et al. (2000). Memory and mood following vagus nerve stimulation for intractable epilepsy. Epilepsia 41 (suppl 7): 136Google Scholar
Reynolds, E. H. (1990). Vigabatrin. Br. Med. J. 300: 277–8CrossRefGoogle ScholarPubMed
Reynolds, E. H. & Travers, R. D. (1974). Serum anticonvulsant concentrations in epileptic patients with mental symptoms. Br. J. Psychiatry 124: 440–45CrossRefGoogle ScholarPubMed
Reynolds, E. H, Chanaurin, I, Milner, G., et al. (1966). Anticonvulsant therapy, folic acid and Vitamin B12 metabolism and mental symptoms. Epilepsia 7: 261–70CrossRefGoogle ScholarPubMed
Reynolds, E. H., Ring, H., & Heller, A. (1988). A controlled trial of gamma-vinyl-GABA (vigabatrin) in drug-resistant epilepsy. Br. J. Clin. Pract. Suppl. 61: 33Google Scholar
Ring, H. A., Moriarty, J. & Trimble, O. (1998). A prospective study of the early postsurgical psychiatric associations of epilepsy surgery. J. Neurol. Neurosurg. Psychiatry 64: 601–4CrossRefGoogle ScholarPubMed
Ring, H. A., Trimble, M. R., Costa, D. C., et al. (1994). Striatal dopamine receptor binding in epileptic psychosesBiol. Psychiatry 356: 375–80CrossRefGoogle Scholar
Rivinus, T. M. (1982). Psychiatric effects of the anticonvulsant regimens. J. Clin. Psychopharmacol. 2: 165–92CrossRefGoogle ScholarPubMed
Robertson, M. M., Trimble, M. R. & Townsend, H. R. A. (1987). Phenomenology of depression in epilepsy. Epilepsia 28: 364–72CrossRefGoogle ScholarPubMed
Rodin, E. A., Choon, S. R., Kitano, H., et al. (1976). A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients. J. Nerv. Ment. Dis. 163: 41–5CrossRefGoogle ScholarPubMed
Rogers, D., Bird, J. & Eames, P. (1993). Complex partial status after starting vigabatrin. Seizure 2: 155–6CrossRefGoogle ScholarPubMed
Rosenstein, D. L., Nelson, J. C. & Jacobs, S. C. (1993). Seizures associated with antidepressants: a review. J. Clin. Psychiatry 54: 289–99Google ScholarPubMed
Ryan, L. M., Malamut, B. L., O'Connor, M. J., et al. (1999). Incidence of depression before and after temporal lobectomy for medically intractable epilepsy. Epilepsia 4 (suppl 7): 58–9Google Scholar
Ryback, R. S. & Ryback, L. (1995). Gabapentin for behavioral dyscontrol. Am. J. Psychiatry 152: 1399Google ScholarPubMed
Ryback, R. S., Brodsky, L. & Mansifi, F. (1997). Gabapentin in bipolar disorder. J. Neuropsychiatry Clin Neurosci. 9: 301CrossRefGoogle ScholarPubMed
Sander, J. A. S., Hart, Y. M, Trimble, M. R., et al. (1991a). Behavioral disturbances associated with vigabatrin therapy. 19th International Epilepsy Congress. Epilepsia 32 (suppl 1): 12Google Scholar
Sander, J. A. S.Hart, Y. M., Trimble, M. R., et al. (1991b). Vigabatrin and psychosis. J. Neurol. Neurosurg. Psychiatry 54: 435–9CrossRefGoogle Scholar
Schaffer, C. B., Schaffer, L. C. (1997). Gabapentin in the treatment of bipolar disorder. Am. J. Psychiatry. 15: 491–2Google Scholar
Schain, R. J. (1983). Carbamazepine and cognitive functioning. In Antiepileptic Drug Therapy in Pediatrics, ed. P. Morselli, C. E. Pippinger & J. K. Penry, pp. 189–92. New York: Raven Press
Schapel, G. & Chadwick, D. (1996). Tiagabine and non-convulsive status epilepticus. Seizure 5: 153–6CrossRefGoogle ScholarPubMed
Schmidt, D. (1992). Epilepsien and epileptische Anfdlle. Stuttgart: Thieme
Schmitz, B. (1999). Psychiatric syndromes related to antiepileptic drugs. Epilepsia 40 (suppl 10): 65–70CrossRefGoogle ScholarPubMed
Schmitz, B. & Trimble, M. R. (1995). Carbamazepine and PIP-syndrome in temporal lobe epilepsy. Epilepsy Res. 22: 215–20CrossRefGoogle ScholarPubMed
Sherard, E. S. Jr, Steiman, G. S. & Couri, D. (1980). Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6 month trial. Neurology 30: 31–5CrossRefGoogle Scholar
Sheth, R. D., Goulden, K. J. & Penney, S. (1992). Catastrophic behavior outbursts requiring discontinuation of clobazam in children. Epilepsia 33 (suppl 3): 100Google Scholar
Shorvon, S. D. (1998). Safety of topiramate: adverse events and relationships to dosing. Epilepsia 37 (suppl 2): 18–22CrossRefGoogle Scholar
Silverstein, F. S., Parrish, M. A. & Johnston, M. V. (1982a). Clinical and laboratory observations – adverse behavioral reactions in children treated with carbamazepine (Tegretol). J. Pediatr. 101: 785–7CrossRefGoogle Scholar
Silverstein, F. S., Parrish, M. A. & Johnston, M. V. (1982b). Adverse reactions to carbamazepine (Tegretol) in children with epilepsy. Ann. Neurol. 12: 198Google Scholar
Small, J. G., Klapper, M. H., Milstein, V., et al. (1991). Carbamazepine compared with lithium in the treatment of mania. Arch. Gen. Psychiatry 48: 915–21CrossRefGoogle ScholarPubMed
Smith, K. R., Goulding, P. M., Wilderman, D., et al. (1994). Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch. Neurol. 51: 653–60CrossRefGoogle ScholarPubMed
Sonnen, A. E. H., Zelvelder, W. H. & Bruens, J. H. (1975). A double blind study of the influence of dipropylacetate on behavior. Acta Neurol. Scand. (suppl) 60: 43–7CrossRefGoogle Scholar
Sporn, J. & Sachs, G, (1997). The anticonvulsant lamotrigine in treatment resistant manic depressive illness. J. Clin. Psychopharmacol. 17: 185–9CrossRefGoogle ScholarPubMed
Stagno, S. J. (1993). The epidemiology of epilepsy. In The Treatment of Epilepsy: Principles and Practice, ed. E. Wyllie, pp. 1149–62. Philadelphia: Lea & Febiger
Stephen, L. J. & Brodie, M. J. (1998). New drug treatments for epilepsy. Prescr. J. 38: 98–106Google Scholar
Stoll, A. L., Banov, M., Kolbrener, M., et al. (1994). Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J. Clin. Psychopharmacol 14: 311–13CrossRefGoogle ScholarPubMed
Stores, G. (1975). Behavioral effects of anti-epileptic drugs. Dev. Med. Child Neurol. 17: 647–58CrossRefGoogle Scholar
Stores, G. (1976). The investigation and management of school children with epilepsy. Lond. Publ. Health. 90: 171–7CrossRefGoogle ScholarPubMed
Stores, G. (1981). Problems of learning and behavior in children with epilepsy. In Epilepsy and Psychiatry, ed. E. H. Reynolds & M. R. Trimble, pp. 33–48. New York: Churchill Livingstone
Suppes, T., Brown, E. S., McElroy, S. L., et al. (1998). A pilot trial of adjunctive topiamate in the treatment of bipolar disorder. Proceedings of the 37th Annual Meeting of the American College of Neuropsychopharmacology pp. 306
Sziklas, V. G., Montour-Proutz, I., Andermann, F., et al. (1999) Cognitive effects of topiramate therapy in patients with intractable partial epilepsy. Epilepsia 40 (suppl 7): 56Google Scholar
Tallian, K. B., Nahata, M. C., Lo, W., et al. (1996). Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 37: 501–6CrossRefGoogle ScholarPubMed
Tassanari, C. A., Michelucci, R., Chauvel, P., et al. (1996). Double-blind, placebo-controlled trila of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 37: 763–8CrossRefGoogle Scholar
Theodore, W. H. & Porter, R. J. (1983). Removal of sedative hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy. Ann. Neurol. 13: 320–24CrossRefGoogle ScholarPubMed
Thomas, L., Trimble, M. R., Schmitz, B., et al. (1996). Vigabatrin and behavior disorders: a retrospective survey. Epilepsy Res. 25: 21–7CrossRefGoogle ScholarPubMed
Thompson, P. J. (1991). Memory function in patients with epilepsy. In Neurobehavioral Problems in Epilepsy, ed. D. Smith, D. Treiman & M. Trimble, Vol. 55, pp. 369–84. New York: Raven Press
Thorn, I. (1975). A controlled study of prophylactic long-term treatment of febrile convulsions with phenobarbital. Acta Neurol. Scand. Suppl. 60: 67–73CrossRefGoogle Scholar
Trimble, M. (1980). Anti-epileptic drugs and behavior – discussion notes. In Epilepsy and Behavior'79, ed. B. M. Kulig, H. Meinardi & G. Stores, pp. 76–9. Lisse: Swets & Zeitlinger
Trimble, M. (1982). Anticonvulsant drugs and hysterical seizures. In Pseudoseizures, ed. T. L. Riley & A. Roy, pp. 148–58. Baltimore, MD: Williams & Wilkins
Trimble, M. R. (1983). Anticonvulsant drugs and psychosocial development: phenobarbitone, sodium valproate and benzodiazepines. In Antiepileptic Drug Therapy in Pediatrics, ed. P. Morselli, C. E. Pippinger & J. Penry, pp. 201–17. New York: Raven Press
Trimble, M. R. (1986). The psychoses of epilepsy and their treatment. In The Psychopharmacology of Epilepsy, pp. 83–94. New York: John Wiley & Sons
Trimble, M. R. (1994). Psychiatric illness in epilepsy: a psychiatrist's perspective. Presented at the American Epilepsy Society Conference, 1994
Trimble, M. R. (1997). Neuropsychiatric consequences of pharmacotherapy. In Epilepsy. A Comprehensive Textbook, ed. J. Engel & T. A. Pedley, pp. 2161–70. Philadelphia: LippincottRaven
Trimble, M. R. (1998). Forced normalization and the role of anticonvulsants. In Forced Normalization, ed. M. R. Trimble & B. Schmitz, pp. 169–78. Petersfield, UK: Wrightson Biomedical
Trimble, M. R. & Cull, C. (1990). Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia 29 (suppl 3): 13–19Google Scholar
Trimble, M. R. & Reynolds, E. H. (1976). Anticonvulsant drugs and mental symptoms: a review. Psychol. Med. 6: 169–78CrossRefGoogle ScholarPubMed
Vaintrub, M. Y. (1998). Initial psychiatric and other disorders due to AED treatment. 3rd European Congress of Epileptology. Epilepsia 39 (suppl 2): 122Google Scholar
Vassilyadi, M., Strawburg, R. H., Weber, A. M., et al. (2000). Vagal nerve stimulation at the children's hospital medial center. Epilepsia 41 (suppl 7): 136Google Scholar
Vickery, B. G., Hayes, R. D., Graber, J., et al. (1992). A health-related quality of life instrument for patients reevaluated for epilepsy surgery. Med. Care. 30: 299–319CrossRefGoogle Scholar
Vining, E. P. G. (1990). Cognitive and behavioral side effects of antiepileptic drugs. Int. Pediatr. 5: 182Google Scholar
Vining, E. P. G., Mellits, E. D., Dorsen, M. M., et al. (1987). Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 80: 165–74Google ScholarPubMed
Weisbrot, D. M. & Ettinger, A. B. (1998). Psychiatric aspects of pediatric epilepsy. Primary PsychiatryJune: 51–67
Wilner, A. (2002). Antiepileptic reduces seizures in children. CNS News 4: 15Google Scholar
Wolf, P. (1991). Acute behavioral symptomatology at disappearance of epileptiform EEG abnormality: paradoxical or “forced” normalization. In Neurobehavioral Problems in Epilepsy: Advances in Neurology, ed. D. Smith, D. Treiman & M. Trimble, pp. 127–42. New York: Raven Press
Wolf, S. & Forsythe, A. (1978). Behavior disturbances, phenobarbital and febrile seizures. Pediatrics 61: 728–31Google Scholar
Wolf, P., Inoue, Z., Roder-Wanner, U. U., et al. (1984). Psychiatric complications of absence therapy and their relation to alteration of sleep. Epilepsia 25: 56–9CrossRefGoogle Scholar
Wolf, S. M., Shinnar, S., Kang, H., et al. (1995). Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 36: 1203–5CrossRefGoogle ScholarPubMed
Young, L. T., Robb, J. C., Patelis-Siotis, I., et al. (1997). Acute treatment of bipolar depression with gabapentin. Biol. Psychiatry 42: 851–3CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×